Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07367451

Effects of Propolis Flavonoids on TLR4 Signaling and Inflammation in Human PDLSCs In Vitro

Effect of Propolis-Derived Flavonoid Extract on TLR4 Signaling and Inflammatory Cytokine Expression in Human Periodontal Ligament Stem Cells (PDLSCs): An In-Vitro Study

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
20 (estimated)
Sponsor
Cairo University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

This in-vitro study evaluated the effects of a flavonoid-rich propolis extract on Toll-like receptor 4 (TLR4) signaling and inflammatory cytokine expression in human periodontal ligament stem cells (PDLSCs). PDLSCs were treated with propolis flavonoids under baseline conditions and following lipopolysaccharide (LPS)-induced inflammation, with untreated cells serving as controls. TLR4 gene expression was analyzed using PCR, while levels of pro-inflammatory cytokines (IL-1β, IL-6, and TNF-α) were quantified by ELISA. Cell viability and cytotoxicity at different extract concentrations were assessed using the MTT assay. The study aimed to determine the immunomodulatory and cytocompatible potential of propolis flavonoids in regulating inflammatory responses in PDLSCs.

Conditions

Interventions

TypeNameDescription
DRUGFlavonoid extract from propolisPreparation of Propolis Flavonoid Extract Concentrations for testing: 5 µg/mL 10 µg/mL 20 µg/mL
OTHERno medication addedNo medication will be added to the second group

Timeline

Start date
2026-01-25
Primary completion
2026-01-30
Completion
2026-02-10
First posted
2026-01-26
Last updated
2026-02-05

Source: ClinicalTrials.gov record NCT07367451. Inclusion in this directory is not an endorsement.